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INTRODUCTION: Merkel cell carcinoma (MCC) is a rare and highly aggressive primary cutaneous neu-
roendocrine carcinoma, most often occurring in the elderly. Recurrence is frequent and in 40% of cases
regional and distant metastases develop. Despite this, there have been reports of spontaneous regres-
sion. We report the ﬁrst case of MCC with primary complete spontaneous regression of the nose in an
86-year-old woman following an incisional biopsy.
PRESENTATION OF CASE: An 86-year-old woman presented with a violaceous lump on the left side of the
nose measuring 25×25mm. Incisional biopsy of the lesion showed MCC and immunohistochemistry
conﬁrmed diagnosis. Following an 8-week period the lesion completely disappeared and histology did
not show any residual MCC but immunohistochemistry demonstrated a mixture of T and B cells.
DISCUSSION: Complete spontaneous regression (CSR) is rare. The literature documents 22 similar cases
of CSR of MCC. From this case report and previous literature the most likely reason for regression is a
T-cell mediated immune response.
CONCLUSION: To the best of our knowledge, this is the ﬁrst described case ofMCCwith primary CSR of the
nose. Exact mechanism of regression remains unclear. Further research is needed in identifying pathway
of immune response and possible immunotherapy as a cure.
© 2014 The Authors. Published by Elsevier Ltd. on behalf of Surgical Associates Ltd. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
1. Introduction
Merkel cells are primarily located in the basal layer of the epi-
dermis and concentrated in touch-sensitive areas of the skin.1
Their most noticeable ultrastructural characteristics are the dense-
core secretory granules accumulated near the nerve ﬁbre junction,
which may contribute to its indeﬁnite neuroendocrine function.2
Merkel cell carcinoma (MCC) was ﬁrst described by Toker3 in
1972 as trabecular carcinoma of the skin. 85% of allMCCs appear on
sun-exposed areas4 with the head and neck regionmost frequently
affected, accounting for 35–47% of these cases.5,6 The prognosis
is poor, with a 5-year survival rate of around 60%7, owing to the
common involvement of regional lymph nodes (10–45%) at initial
presentation, of which 50–75% of patients develop regional lymph
node metastases at some time.8–12 Distant metastases commonly
affects 50% of patients with common sites being the lymph nodes,
liver, bone, brain, lung and skin.8–10,13,14
∗ Corresponding author. Tel.: +44 7799060368.
E-mail addresses: cp266@student.le.ac.uk (C. Pang),
deepika.sharma@uhl-trh.nhs.uk (D. Sharma), thangasamy.sankar@kgh.nhs.uk
(T. Sankar).
O’Rouke and Bell15 ﬁrst described complete spontaneous
regression (CSR) of MCC in 1986. Thereafter, 21 additional cases
have been reported. This present study presents a case of complete
spontaneous regression of MCC with an immunohistochemistry
study of the region in which the tumour was located.
2. Presentation of case
An86-year-old femalepatientpresentedwithaviolaceous lump
on the left side of the nose measuring 25×25mm. An incisional
biopsy was performed and histology showed a dense inﬁltrate of
small tumour cellswith hyperchromatic nuclei and little cytoplasm
(Fig. 1). Immunohistochemistry conﬁrmed the diagnosis of MCC,
with positive staining for cytokeratin 20 (CK20) (Fig. 2), neuron-
speciﬁc enolase (Fig. 3), synaptophysin and negative staining for
cytokeratin 5/6T, TTF1 and MelanA. The patient attended for an
excision 8 weeks after her initial biopsy and showed no presence
of lump prior to excision (Fig. 4). Histology of the excised specimen
showed severely sun-damaged skin with mild epidermal atrophy.
There was a patchy chronic inﬂammatory cell inﬁltrate with focal
ﬁbrosis and foreign body giant cell reactionwith no evidence of any
residual MCC. Immunohistochemistry demonstrated a mixture of
both T and B cells with positive staining for CD4, CD3, CD5, and
http://dx.doi.org/10.1016/j.ijscr.2014.11.027
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Fig. 1. Histopathological examination showingdense inﬁltrate of small tumour cells
with hyperchromatic nuclei and little cytoplasm. (A) Haematoxylin-eosin, magniﬁ-
cation 20×. (B) Haematoxylin-eosin, magniﬁcation 400×.
CD8 with CD4 slightly more than CD20 and CD79a. In addition,
the specimen revealed admixed macrophages, which stained with
CD68.
3. Discussion
Spontaneous regression among all neoplastic diseases has been
estimated to be 1 case per 60,000 to 100,000 neoplasms.16 Com-
plete spontaneous regression (CSR) of MCC is rare and predicted
to be 0.0013%.17 To date, 15 cases of complete MCC regression fol-
lowing incisional biopsy have been reported (Table 1), along with
7 cases of regression occurring after local or regional recurrence of
Fig. 2. Positive immunostaining for cytokeratin 20 showing adot-like pattern (mag-
niﬁcation 400×).
Fig. 3. Positive immunostaining for neurone-speciﬁc enloase (magniﬁcation 400×).
the carcinoma (Table 2). In the group of MCCs with primary CSR
most neoplasms were located on the cheek. In contrast, none of
the cases of MCCs with CSR after local recurrence or metastasis
were primarily located on the cheek. In both groups of patients the
majority were female (15 cases) and the mean age was 79 years
old. Our patient presented the typical characteristics of patients
with primary CSR of MCC i.e. female sex, elderly and regression
after incisional biopsy.
The histopathologic study of the biopsy following CSR in our
patient demonstrated results similar to other reports.18–20 The
biopsy showed accumulation of chronic inﬂammatory cells,mainly
T cells. Other studies of both primary and secondary MCC demon-
strated inﬁltration by CD4+, CD8+ and CD3+ T lymphocytes and
foamy macrophages.17–21 The mechanism of CSR remains unclear,
however, along with our ﬁndings, it suggests that T-cell-mediated
immunity plays an important role in tumour regression. This could
be attributed to the initial incisional biopsy of MCC (15 cases),
whichmay have triggered tumour regression via stimulation of the
immune system. In addition, the majority of patients were elderly
with poor health status and various co-morbidities, which may
suggest other unknown mechanisms, could be involved.
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Table 1
Cases reported with primary complete spontaneous regression of Merkel cell carcinomas.
Author Sex/age Co-morbidities Tumour Site Treatment Immunological study after
regression
Disease free
period
Kayashima et al.18 F/68 Forehead Biopsy CD3 and CD5 (pan-T cells) cells
heavily inﬁltrated and few
CD19 cells (B cells). CD4 cells
were in the majority. CD1
(langerhans) cells also present
11 years
Kayashima et al.18 F/86 Hypertension Cerebral
atherosclerosis, IDDM
Cheek Biopsy Inﬁltrates of inﬂammatory
cells (chieﬂy lymphocytes)
36 months
Djilali-Bouzina et al.22 F/83 Cheek Biopsy 1 year
Duncan and Tschen23 M/79 Scalp Biopsy 28 months
Tanita et al.24 F/75 Cheek Biopsy 1 year
Satoh et al.25 M/87 Cheek Biopsy 2 months
Maruo et al.19 F/82 Cervical spinal cord injury and
complete paresis, Cerebral
atherosclerosis and Neurosis
Cheek Biopsy Large number of KP-1+ foamy
cells (macrophages).
Inﬁltration of lymphocytes,
numerous lymphoid follicles
and T cells
1 year
Connelly et al.26 F/71 Cheek Biopsy 11 months
Sais et al.27 F/78 Thigh Biopsy 40 months
Junquera et al.28 F/79 Cheek Biopsy Dense cluster of lymphocytes
and ﬁbrosis
6 years
Vesely et al.20 F/67 Cheek Biopsy Prominent lymphocytic
inﬁltrate
6 months
Missotten et al.16 M/90 Eyelid Biopsy Granulomatous inﬂammation
consisting of many histiocytes
and lymphocytes
18 months
Missoten et al.6 F/81 Eyelid Biopsy 2 years
Ciudad et al.7 F/86 Cheek Biopsy Moderate lymphocytic
inﬁltrate. Most lymphocytes
were T cells
18 months
Ciudad et al.17 M/92 High blood pressure, Diabetes
mellitus, Parkinson’s Disease,
Glaucoma, Dementia
Scalp Biopsy 23 months
Present Study F/86 Osteoarthritis, COPD,
Hypertension, AF, PPM
(pacemaker)
Nose Biopsy Lymphocyte inﬁltrate staining
for CD4+, CD3+, CD5+ with
CD4+ slightly more than CD20+
and CD79a. Also admixed
macrophages present staining
for CD68
Table 2
Cases reported with complete spontaneous regression of recurrences or metastasis of Merkel cell carcinomas.
Author Sex/age Co-morbidities Tumour site Treatment Metastasis Immunological study
after regression
Disease free
period
O’Rourke and Bell15 F/90 Cerebral atherosclerosis,
SCC upper sternum
Pre-auricular
area
Surgery Skin 18 months
Bayrou et al.29 F/69 Temple Surgery,
radiotherapy,
chemother-
apy
Cervical
lymphadenopathy
and Skin
15 years
Yanguas et al.30 M/65 Dilated cardiomyopathy,
Mitral insufﬁciency,
Hypertension, Atrial
ﬁbrillation, Transient
ischaemic attacks, Chronic
renal failure, Abdominal
aortic aneurysm
Ear Surgery Cervical
lymphadenopathy
and Skin
18 months
Connelly and
Kowalcyk31
M/85 Forehead Surgery Intraparotid
lymphadenopathy
and Skin
50 months
Brown et al.32 M/85 Scalp Surgery Cervical
lymphadenopathy
and Skin and Bone
33 months
Richetta et al.33 F/76 Eyebrow Surgery Regional lymph
nodes and Skin
Fibrosis, vascular
congestion and modest
lymphocytic inﬁltrate
13 months
Wooff et al.21 F/94 Eyebrow Surgery Regional lymph
nodes
Extensive ﬁbrosis with
accumulation of foamy
macrophages and other
chronic inﬂammatory
cells including many T
lymphocytes
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Fig. 4. (A and B) Spontaneous regression of Merkel cell carcinoma after incisional biopsy.
4. Conclusion
In summary, we report one patient with CSR of MCC. To the
best of our knowledge, this is the ﬁrst described case of MCC with
primaryCSRof thenose. Theﬁndings are in concordancewithmany
other studies most notably an incisional biopsy before regression
and an inﬁltrate of T cells after regression. Although, this is only
a proposed mechanism it certainly is an area that requires further
research with the possibility of developing immune modulating
therapy in treating such cancers.
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Key learning points
• Merkel cell carcinoma is a rare disease with a high metastatic rate and poor prognosis.
• Spontaneous regression of Merkel cell carcinoma is an extremely rare event.
• In this case report, regression occurred following incisional biopsy.
• Biopsy showed mainly T cells suggesting immunity plays an important role in tumour regression which may be
attributed to the incision which triggered an immune response.
• Mechanism of regression is still unclear but research into immune modulating therapy may help in managing such
cancers.
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